What we offer
The Adult Congenital Heart Program at Stanford specializes in treating adults who were born with congenital heart defects. Although most patients will have undergone corrective surgery, some may not have been previously treated, or may have recently discovered complex residual conditions requiring therapy involving drugs, interventional procedures, or surgery.
The Adult Congenital Heart Program at Stanford offers:
- Leading cardiothoracic surgeons who are experts in repairing congenital heart lesions across all age groups.
- A highly specialized program specifically designed for adolescent and adult patients with congenital heart defects.
- Advanced treatment options for pulmonary valve repair in patients with tetralogy of Fallot, transcatheter ASD closure, and pulmonary valve replacement, as well as alternative therapies such as ventricular assist devices and heart/lung transplantation.
Our collaboration and accreditation
The Adult Congenital Heart Program at Stanford—a collaboration between Stanford Children's Health and Stanford Health Care—is an Adult Congenital Heart Association (ACHA) Adult Congenital Heart Disease (ACHD) Accredited Program. This makes the Adult Congenital Heart Program a premier comprehensive care center in the U.S. for congenital heart defect patients.
Our program focuses on a smooth transition from pediatric cardiology to adult heart care that continues to provide comprehensive, ongoing care to adult patients throughout their life.
Accreditation by the ACHA ACHD acknowledges that a center has the capability to bring high quality of care to congenital heart diseaes patients. This includes:
We also offer a Patient and Family Advisory Council (PFAC) to provide an ongoing level of support and quality of care to patients and their families.
The Adult Congenital Heart Program at Stanford treats the full spectrum of pediatric and adult congenital heart diseases. To learn more about pediatric congenital heart diseases, visit Stanford Children's Health.
Volume & Outcomes
The Adult Congenital Heart Program at Stanford has quickly grown to have some of the highest surgical volumes in the country, demonstrating our experience and superior outcomes.
The 30-day survival rates above reflect adult congenital heart surgeries performed from 2019-2021.